XML 8 R2.htm IDEA: XBRL DOCUMENT v3.24.4
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 77 $ 3,921
Accounts receivable, net 31,580 34,597
Inventory 2,404 4,214
Prepaid expenses and other 5,794 4,049
Total current assets: 39,855 46,781
Property and equipment, net 711 722
Operating lease right-of-use asset 2,396 2,943
Intangibles, net 33,454 36,485
Investments 2,375 0
Goodwill 13,481 13,481
Other long term assets 8,158 897
Total assets 100,430 101,309
Current liabilities:    
Accounts payable 43,400 40,954
Accrued payroll 975 2,681
Accrued rebates and fees 141,709 89,658
Accrued expenses 9,671 7,408
Current portion of deferred consideration 458 491
Debt, current 84,636 108,429
Current portion of operating lease liabilities 688 759
Total current liabilities: 281,537 250,380
Long-term portion of deferred consideration 2,556 2,895
Debt, net of issuance costs 14,332 17,038
Derivative liabilities 11,453 1,518
Operating lease liabilities 1,714 2,237
Other long-term liabilities 155 179
Total liabilities 311,747 274,247
Commitments and contingencies (See Note 11)
Stockholders' deficit:    
Preferred stock, $0.0001 par value, 45,000,000 shares authorized; 29,057,097 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively 0 0
Common stock, $0.0001 par value, 740,000,000 shares authorized; 191,790,520 shares issued and 131,721,935 shares outstanding as of September 30, 2024; 160,084,250 shares issued and 100,015,665 shares outstanding as of December 31, 2023 19 16
Additional paid-in capital 430,767 407,813
Accumulated other comprehensive income 5,011 0
Accumulated deficit (556,592) (490,245)
Treasury stock, at cost; 60,068,585 shares as of each of September 30, 2024 and December 31, 2023 (90,522) (90,522)
Total stockholders' deficit (211,317) (172,938)
Total liabilities and stockholders' deficit $ 100,430 $ 101,309